147 filings
ARS
2023 FY
IDYA
Ideaya Biosciences Inc
24 Apr 24
Annual report to shareholders
4:00pm
DEF 14A
IDYA
Ideaya Biosciences Inc
Definitive proxy
19 Apr 24
9:00am
8-K
IDYA
Ideaya Biosciences Inc
12 Mar 24
IDEAYA Announces Clinical Collaboration to Evaluate IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer
6:04am
S-8
IDYA
Ideaya Biosciences Inc
20 Feb 24
Registration of securities for employees
4:31pm
10-K
2023 FY
IDYA
Ideaya Biosciences Inc
Annual report
20 Feb 24
4:05pm
8-K
1b9gyczn
20 Feb 24
IDEAYA Biosciences, Inc. Reports Fourth Quarter and Full-Year 2023
6:07am
8-K
ulf7r
23 Jan 24
Other Events
6:03am
8-K
jqkrt6w
19 Jan 24
Entry into a Material Definitive Agreement
5:18pm
424B5
7u1p4 sme7
19 Jan 24
Prospectus supplement for primary offering
5:15pm
8-K
a2ileey
16 Jan 24
Other Events
6:07am
8-K
0juhvgli
12 Jan 24
Other Events
6:04am
8-K
g6pqykwx
4 Dec 23
IDEAYA Announces Clinical Study Collaboration with Gilead Sciences to Evaluate Trodelvy® and IDE397 Combination in MTAP-Deletion Bladder Cancer
6:04am
8-K
adoisyzwr019d9
17 Nov 23
Entry into a Material Definitive Agreement
6:02am
8-K
47q0n k51m06gbe8x1s0
7 Nov 23
IDEAYA Biosciences, Inc. Reports Third Quarter 2023
6:01am
8-K
ns9mlwemg l1
27 Oct 23
Other Events
4:23pm
424B5
aelm0l9j
25 Oct 23
Prospectus supplement for primary offering
9:45pm
424B5
jw7igfz
24 Oct 23
Prospectus supplement for primary offering
5:26pm
8-K
i3apm4hx7 qry
24 Oct 23
Results of Operations and Financial Condition
4:21pm
8-K
4737ilut yifws6
23 Oct 23
Other Events
8:09am